United Capital Financial Advisors LLC bought a new position in Rocket Lab Corporation (NASDAQ:RKLB - Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 13,424 shares of the rocket manufacturer's stock, valued at approximately $1,365,000.
Other hedge funds have also bought and sold shares of the company. BlackRock Inc. bought a new stake in shares of Rocket Lab during the 2nd quarter valued at $4,124,970,000. Capital World Investors grew its position in Rocket Lab by 12.0% during the fourth quarter. Capital World Investors now owns 16,200,726 shares of the rocket manufacturer's stock worth $1,130,172,000 after buying an additional 1,738,623 shares in the last quarter. Bank of New York Mellon Corp purchased a new stake in shares of Rocket Lab in the 2nd quarter valued at about $245,764,000. State Street Corp grew its holdings in shares of Rocket Lab by 1.0% during the fourth quarter. State Street Corp now owns 12,520,223 shares of the rocket manufacturer's stock worth $873,411,000 after purchasing an additional 120,652 shares in the last quarter. Finally, Geode Capital Management LLC increased its position in shares of Rocket Lab by 10.1% in the fourth quarter. Geode Capital Management LLC now owns 9,004,724 shares of the rocket manufacturer's stock worth $626,605,000 after purchasing an additional 825,158 shares during the last quarter. 71.78% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
A number of research firms have commented on RKLB. Weiss Ratings reissued a "sell (d-)" rating on shares of Rocket Lab in a research note on Friday, July 17th. KGI Securities raised Rocket Lab from a "neutral" rating to an "outperform" rating and set a $107.00 target price on the stock in a research note on Monday, July 27th. New Street Research started coverage on Rocket Lab in a research note on Wednesday, May 13th. They set a "buy" rating and a $150.00 price target for the company. Roth Capital set a $110.00 price objective on Rocket Lab in a research report on Tuesday, August 11th. Finally, Citizens Jmp restated a "market outperform" rating and issued a $130.00 target price on shares of Rocket Lab in a research report on Tuesday, August 11th. Three investment analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating, five have given a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $110.65.
Read Our Latest Stock Report on RKLB
Rocket Lab Stock Performance
Rocket Lab stock opened at $64.39 on Friday. The company has a current ratio of 5.48, a quick ratio of 4.98 and a debt-to-equity ratio of 0.01. The firm has a market cap of $38.53 billion, a P/E ratio of -238.47 and a beta of 2.60. Rocket Lab Corporation has a 1-year low of $37.57 and a 1-year high of $151.00. The firm has a 50-day moving average of $77.80 and a 200-day moving average of $84.98.
Rocket Lab (NASDAQ:RKLB - Get Free Report) last issued its quarterly earnings data on Monday, August 10th. The rocket manufacturer reported ($0.08) earnings per share for the quarter, missing analysts' consensus estimates of ($0.06) by ($0.02). Rocket Lab had a negative return on equity of 6.48% and a negative net margin of 21.51%.The business had revenue of $234.07 million during the quarter, compared to the consensus estimate of $231.62 million. Sell-side analysts expect that Rocket Lab Corporation will post -0.2 EPS for the current year.
Insider Activity at Rocket Lab
In related news, CEO Peter Beck sold 1,298,622 shares of the stock in a transaction dated Tuesday, July 7th. The shares were sold at an average price of $84.92, for a total value of $110,278,980.24. Following the completion of the transaction, the chief executive officer directly owned 2,715,181 shares of the company's stock, valued at $230,573,170.52. This represents a 32.35% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Arjun Kampani sold 88,000 shares of the firm's stock in a transaction that occurred on Thursday, June 18th. The shares were sold at an average price of $107.98, for a total value of $9,502,240.00. Following the completion of the transaction, the senior vice president owned 264,705 shares of the company's stock, valued at approximately $28,582,845.90. The trade was a 24.95% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 3,524,214 shares of company stock valued at $309,110,848 over the last three months. Corporate insiders own 8.40% of the company's stock.
Key Headlines Impacting Rocket Lab
Here are the key news stories impacting Rocket Lab this week:
- Positive Sentiment: Defense and space-systems demand remain important growth drivers. Rocket Lab is benefiting from its selection by Viasat to build spacecraft buses for the U.S. Space Force’s Protected Tactical SATCOM-Global program. Its HASTE hypersonic test platform is also expanding the company’s exposure to Pentagon missions, supporting the view that Rocket Lab is more than an Electron launch provider. Rocket Lab HASTE defense coverage
- Positive Sentiment: Electron execution and analyst revisions offer potential support. Rocket Lab has reached 93 Electron launches, while some analysts have raised earnings estimates. A hammer chart pattern has also prompted bottom-fishing interest after the decline. Rocket Lab bottom-fisher coverage
- Neutral Sentiment: Analysts remain broadly bullish, but the valuation requires strong execution. Rocket Lab carries a reported “Moderate Buy” consensus and an average price target of $110.65, but the company remains unprofitable and trades at a high valuation relative to current earnings. Its elevated beta also leaves the stock vulnerable to sharp swings.
- Negative Sentiment: Neutron timing is the largest operational risk. Reports that the medium-lift Neutron rocket’s first launch could slip into 2027 have weakened a key investment thesis. The delay would postpone a major revenue and valuation catalyst while extending development costs. Rocket Lab Neutron timeline coverage
- Negative Sentiment: Insider selling adds to near-term pressure. Five executives sold approximately $5.5 million of shares, including sizable sales by the CFO and COO. The transactions were made under Rule 10b5-1 plans to cover tax withholding on vested restricted stock units, reducing their significance, though no comparable insider buying was reported. Rocket Lab executive sale coverage
- Negative Sentiment: Profitability remains a concern. Rocket Lab’s latest quarterly revenue exceeded expectations, but its $0.08-per-share loss was wider than forecast. Continued annual losses make the stock particularly sensitive to acquisition uncertainty, Neutron delays, and any slowdown in launch or defense growth.
About Rocket Lab
(
Free Report)
Rocket Lab is an aerospace company that provides launch services, spacecraft, and space systems for commercial and government customers. The company's primary launch vehicle is Electron, a small-lift orbital rocket designed to deploy small satellites and rideshare payloads to low Earth orbit. Rocket Lab also develops and manufactures the Rutherford engine, noted for its electric-pump-fed design and additive-manufactured components, which powers Electron and supports the company's propulsion capabilities.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Rocket Lab, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rocket Lab wasn't on the list.
While Rocket Lab currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.